Literature DB >> 20521934

Human cytomegalovirus latent infection and associated viral gene expression.

Barry Slobedman1, John Z Cao, Selmir Avdic, Bradley Webster, Samantha McAllery, Allen Kl Cheung, Joanne Cg Tan, Allison Abendroth.   

Abstract

Human cytomegalovirus (HCMV) is a clinically important and ubiquitous herpesvirus. Following primary productive infection the virus is not completely eliminated from the host, but instead establishes a lifelong latent infection without detectable virus production, from where it can reactivate at a later stage to generate new infectious virus. Reactivated HCMV often results in life-threatening disease in immunocompromised individuals, particularly allogeneic stem cell and solid organ transplant recipients, where it remains one of the most difficult opportunistic pathogens that complicate the care of these patients. The ability of HCMV to establish and reactivate from latency is central to its success as a human pathogen, yet latency remains very poorly understood. This article will cover several aspects of HCMV latency, with a focus on current understanding of viral gene expression and functions during this phase of infection.

Entities:  

Mesh:

Year:  2010        PMID: 20521934     DOI: 10.2217/fmb.10.58

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  31 in total

Review 1.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

2.  Mechanisms modulating immune clearance during human cytomegalovirus latency.

Authors:  Barry Slobedman; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.

Authors:  Matthew B Reeves; John H Sinclair
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

Review 4.  Diverse immune evasion strategies by human cytomegalovirus.

Authors:  Vanessa Noriega; Veronika Redmann; Thomas Gardner; Domenico Tortorella
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations.

Authors:  Emily R Albright; Robert F Kalejta
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

6.  Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product.

Authors:  Joanne C G Tan; Selmir Avdic; John Z Cao; Edward S Mocarski; Kirsten L White; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.

Authors:  Selmir Avdic; John Z Cao; Allen K L Cheung; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

9.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

10.  Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon.

Authors:  Brian P McSharry; Simone K Forbes; John Z Cao; Selmir Avdic; Emily A Machala; David J Gottlieb; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.